BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2024 1:28:46 PM | Browse: 346 | Download: 913
 |
Received |
|
2023-11-24 10:41 |
|
Peer-Review Started |
|
2023-11-24 10:43 |
|
First Decision by Editorial Office Director |
|
2023-12-15 02:01 |
|
Return for Revision |
|
2023-12-15 02:01 |
|
Revised |
|
2023-12-22 09:25 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-01-22 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-01-22 04:22 |
|
Articles in Press |
|
2024-01-22 04:22 |
|
Edit the Manuscript by Language Editor |
|
2024-01-27 21:10 |
|
Typeset the Manuscript |
|
2024-02-08 12:37 |
|
Publish the Manuscript Online |
|
2024-02-26 13:28 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Non-steroidal anti-inflammatory drugs before endoscopic ultrasound guided tissue acquisition to reduce the incidence of post procedural pancreatitis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mike de Jong, Foke van Delft, Christine Roozen, Erwin-Jan van Geenen, Tanya Bisseling, Peter Siersema and Marco Bruno |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mike de Jong, MD, MSc, Research Fellow, Department of Gastroenterology and Hepatology, Radboud University Medical Center, 10 Geert Grooteplein Zuid, Nijmegen 6525 GA, Netherlands. mike.dejong@radboudumc.nl |
| Key Words |
Pancreatitis; Endoscopic ultrasound; Tissue acquisition; Nonsteroidal anti-inflammatory drugs; Pancreatic cancer |
| Core Tip |
Post-endoscopic ultrasound (EUS) pancreatitis has an incidence of 1%-2%. Literature on the effectiveness of diclofenac in preventing a post EUS-tissue-acquisition (TA) pancreatitis is scarce. Based on the pathophysiological mechanism, which is nearly the same in both post-endoscopic retrograde cholangio pancreatography and post-EUS pancreatitis, diclofenac could be effective as prophylaxis of post-EUS-TA pancreatitis. There are several arguments in favor of administration, such as the cost-effective prevention of post-EUS-TA pancreatitis, which could have potentially disastrous consequences for the patient. In addition, a single suppository of diclofenac has limited side effects. In conclusion, administration of diclofenac prior to EUS-TA procedure should be strongly advised to prevent developing post-EUS-TA pancreatitis. |
| Publish Date |
2024-02-26 13:28 |
| Citation |
de Jong M, van Delft F, Roozen C, van Geenen EJ, Bisseling T, Siersema P, Bruno M. Non-steroidal anti-inflammatory drugs before endoscopic ultrasound guided tissue acquisition to reduce the incidence of post procedural pancreatitis. World J Gastroenterol 2024; 30(8): 811-816 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i8/811.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i8.811 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
